Skip to content

A better way to biomanufacture is here

Multiplexed measurements

Reduce process development time

Enable automation and control

Efficient deployment of resources

Real-time, actionable data

Next Generation Bioprocess Control

Modern biotechnology has advanced greatly over the last 50 years, from engineering human insulin to monoclonal antibodies. Although the complexity of the molecules has increased, as well as genetic engineering efficiency, the biomanufacturing industry is well behind others in process control and automation. Lack of control and automation leads to lack of quality, thus continues to drive long development times and large development costs. 

Nirrin Technologies provides the next generation of sensors and analytics that enable bioprocess automation with real-time, in-process monitoring for upstream and downstream applications for the biopharma and life science industries.

  • Real-time insights with in-process monitoring of critical analytes
  • Enable continuous control for critical upstream and downstream bioprocess parameters
  • Faster process development time utilizing real-time actionable data 

How it Works

Proprietary tunable laser technologies

High speed, Optimized power

Patented plug-and-play optical probes

Best-in-class signal-to-noise, Plug-and-play form factors

Automated analytics with industry standard I/O

Automated analysis, Real-time, actionable data

Enabling the Future of Biomanufacturing

At Nirrin, we are committed to design, develop, manufacture high quality sensor and integration technologies for mammalian cell culture, microbial fermentations, cell therapy, and gene-therapy.

Our enabling technology utilizes breakthrough analytical methods to deliver accurate, reliable, and simple-to-use solutions to reduce costs and time-to-market while increasing process control and data insights.

Nirrin is building the foundation to enable continuous control and automation with real-time, actionable bioreactor data.

[LATEST NEWS] Gamma Biosciences Makes Strategic Investment in Nirrin Technologies